Join Us at the AACR Annual Meeting 2021



We are showcasing MammaPrint® and BluePrint® genomic tests for comprehensive profiling of early-stage breast cancer.

Register for the meeting and visit our virtual booth


E-Poster Presentation Information


E-Poster Title:

The FLEX real-world data platform explores new gene expression profiles and investigator initiated protocols in early stage breast cancer

Dr. Adam Brufsky

Session Type: E-Poster Session
Session Category: Phase III Clinical Trials in Progress
Session Title: Phase III Clinical Trials in Progress
Permanent Abstract Number: CT260

FOR PROVEN RESULTS

Trusted by leading physicians and institutions around the world

Our Tests

At the genomic level, physicians can examine the activity of specific genes inside a tumor – how they interact to drive the behavior of a tumor.

Genomic Testing Cell Photo

Landmark Studies

Data on the validation and utility of MammaPrint and BluePrint for patients with early stage breast cancer.

Two women reading about genomic breast cancer results

Latest News

The most recent data and news from Agendia to keep you up-to-date on how our tests can support you and your patients.

For the US, Puerto Rico, and South America

Agendia Inc. USA
22 Morgan
Irvine, CA 92618
(888) 321-2732
customercare@agendia.com


For outside the Americas

Agendia NV
Radarweg 60
1043 NT Amsterdam
The Netherlands
customerservice@agendia.com
+31 (0)20 462 1510